Trial Profile
Efficacy of Biosimilar epoetin alfa in treatment of Anaemia in patients with Multiple Myeloma:a pilot,observational study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2017
Price :
$35
*
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- 10 May 2017 New trial record
- 01 May 2017 Results published in the Annals of Hematology